Detection of HBV YMDD Mutation by Sequencing Method.
- Author:
Yong Hak SOHN
1
;
Choong Hwan CHA
;
Seongsoo JANG
;
Han Joo LEE
;
Kwan Je LEE
;
Eun Soon SHIN
;
Heung Bum OH
Author Information
1. Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. hboh@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Hepatitis B virus;
Lamivudine resistance;
YMDD motif variants
- MeSH:
DNA;
Hepatitis B virus;
Hepatitis B, Chronic;
Humans;
Lamivudine;
Seoul
- From:The Korean Journal of Laboratory Medicine
2003;23(4):292-297
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: YMDD motif variants of the hepatitis B virus (HBV) emerge in some chronic hepatitis B patients after prolonged lamivudine treatment. HBV DNA breakthrough may be accompanied by the emergence of YMDD variants. The detection of YMDD motif variants will be necessary since Adefovir dipivoxil was recently approved to be an effective treatment for lamivudine-resistant patients. METHODS: Samples were chosen from twenty-one patients who experienced the DNA breakthrough after an undetectable HBV DNA period by HBV DNA hybrid-capture assay. We tested the samples of each stage for detection of YMDD motif variants by a sequencing method using Accu-Typer(TM) HBV YMDD typing Kit (DNA Link, Seoul, Korea) and ABI PRISM 3700 DNA Analyzer. RESULTS: All 17 samples that were collected before treatment had the wild-type YMDD motif. Of 20 samples amplified, which were from the undetectable HBV DNA period, three (15%) samples showed YMDD mutation. After DNA breakthrough, YMDD mutants were detected in 13 (63%) of 21 samples (YIDD 8 cases, YVDD 5 cases). CONCLUSION: We could reconfirmed that YMDD motif variants were remarkably related to the lamivudin resistance. YMDD motif variants; however, were not detected in one-third of the lamivudine resistance. The sequencing method of our study would be useful in providing the neighboring nucleotide information other than the YMDD motif in patients experiencing DNA breakthrough.
